This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Optimal Timing of Carbon Dioxide Insufflation During Colonoscopy in Unsedated Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Peng-Jen Chen, Tri-Service General Hospital
ClinicalTrials.gov Identifier:
NCT01415076
First received: August 10, 2011
Last updated: September 3, 2012
Last verified: September 2012
  Purpose
Insufflation of carbon dioxide (CO2) instead of air can reduce pain resulting from colon distension after colonoscopy because CO2 is rapidly absorbed from the colon and excreted through the lungs. This reduces the effects of colonic distension and minimizes intracolonic gas at the end of the examination. The aims of the study were to evaluate the timing of administering CO2 insufflation and to identify predictors of discomfort for colonoscopy.

Condition Intervention
Outpatients Procedure: Insufflation with CO2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Health Services Research
Official Title: The Optimal Timing of Carbon Dioxide Insufflation During Colonoscopy in Unsedated Patients

Resource links provided by NLM:


Further study details as provided by Peng-Jen Chen, Tri-Service General Hospital:

Primary Outcome Measures:
  • abdominal pain during and after colonoscopy [ Time Frame: One day ]
    Pain was recorded on a ten-point visual analog scale (0- no pain, 10- worst imaginable pain) at left-sided colonoscopic insertion, right-sided colonoscopic insertion, and at 1, 3, 6, and 24 hours postprocedure.


Secondary Outcome Measures:
  • delayed bleeding [ Time Frame: One day ]
  • colonoscopic cecal intubation time [ Time Frame: One day ]
  • completeness of intubation [ Time Frame: One day ]
  • loop formation [ Time Frame: One day ]

Enrollment: 200
Study Start Date: September 2010
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Insertion without CO2 insufflation
Patients were randomly allocated to receive whole procedure or extubation-only CO2 insufflation, using a randomized computer-generated list.
Procedure: Insufflation with CO2
Patients were randomly allocated to receive whole procedure or extubation-only CO2 insufflation, using a randomized computer-generated list.
Other Name: the Olympus UCR Endoscopic CO2 Regulation Unit
Experimental: Insertion with CO2
Patients were randomly allocated to receive whole procedure or extubation-only CO2 insufflation, using a randomized computer-generated list.
Procedure: Insufflation with CO2
Patients were randomly allocated to receive whole procedure or extubation-only CO2 insufflation, using a randomized computer-generated list.
Other Name: the Olympus UCR Endoscopic CO2 Regulation Unit

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients with an appropriate indication for colonoscopy were considered eligible.

Exclusion Criteria:

  • Exclusion criteria included severe hematochezia, acute colonic pseudo-obstruction, known obstructive lesions, age <18 years, prior colon resection, fulminant colitis, chronic obstructive pulmonary disease requiring oxygen, and a medical history of CO2 retention. Patients that required only a partial colonoscopy or were unable to read or understand Chinese were also excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01415076

Locations
Taiwan
Division of Gastroenterology, Tri-Service General Hospital
Taipei, Taiwan, 114
Sponsors and Collaborators
Tri-Service General Hospital
Investigators
Study Chair: Tsai-Yuan Hsieh, MD.PhD Division of Gastroenterology, Tri-Service General Hospital
  More Information

Responsible Party: Peng-Jen Chen, Dr., Tri-Service General Hospital
ClinicalTrials.gov Identifier: NCT01415076     History of Changes
Other Study ID Numbers: TSGH-C99-062
Study First Received: August 10, 2011
Last Updated: September 3, 2012

ClinicalTrials.gov processed this record on June 28, 2017